Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Head and Neck Squamous Cell Carcinoma Cell Line
100%
Head and Neck Cancer Cell Line
100%
In Vitro
100%
Tumor Cell
75%
Streptolysin
75%
Squamous Cell
50%
Neck
50%
Reverse Transcriptase
50%
Adenoviridae
50%
Antineoplastic Activity
50%
Infection
50%
Pretreatment
50%
Cell Cycle
25%
Gene Expression
25%
Promoter Region
25%
Oncogene C Myc
25%
Real-Time Polymerase Chain Reaction
25%
Infectious Disease
25%
Replication
25%
Keyphrases
Cancer Cell Lines
100%
Head-and-neck Cancer
100%
In Vitro Sensitivity
100%
Telomelysin
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
54%
Paclitaxel
36%
Cisplatin
36%
Squamous Carcinoma Cells
36%
Carcinoma Cell Line
36%
Tumor Cells
27%
Antitumor Effect
27%
Streptolysin O
27%
OBP-301
27%
Antitumor Activity
18%
Phase Fraction
18%
Cell Doubling Time
18%
Quantitative PCR
9%
Flow Cytometry
9%
Gene Expression
9%
MTT Assay
9%
Clinical Trials
9%
C-Myc
9%
Telomerase
9%
Human Telomerase Reverse Transcriptase (hTERT)
9%
Drug-resistant Tumor
9%
Infectivity
9%
Life Cycle Analysis
9%
Adenovirus Receptor
9%
Human Neck
9%
Human Head
9%
Human Telomerase Reverse Transcriptase Promoter
9%
Spearman Correlation Coefficient
9%
Doubling Time
9%
Significant Relationships
9%
Conditionally Replicative Adenovirus (CRAd)
9%